Oxford Textbook of Cancer Biology
202,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
101 °P sammeln
  • Gebundenes Buch

The Oxford Textbook of Cancer Biology brings together the multifaceted branches of the study of cancer biology into one coherent volume, providing a comprehensive and up-to-date account of this complex and rapidly evolving field.

Andere Kunden interessierten sich auch für
Produktbeschreibung
The Oxford Textbook of Cancer Biology brings together the multifaceted branches of the study of cancer biology into one coherent volume, providing a comprehensive and up-to-date account of this complex and rapidly evolving field.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Francesco Pezzella is Professor of Tumour Pathology at the University of Oxford, UK, and Consultant Pathologist at the Oxford University Hospitals. His early work focused on the pathology of HIV and its effect on lymph nodes, followed by the molecular alterations of non-Hodgkin's Lymphoma. His research then turned to cancer and blood vessels, whereby he discovered the non-angiogenic pathway of the growth of human cancers, leading to a change in one of the hallmarks of cancer. Professor Pezzella continues to specialise in haematopathology and has published over 200 papers. Mahvash Tavassoli is Professor of Molecular Oncology at King's College London, UK. She has held several positions internationally, including at the Fred Hutchinson Cancer Research Centre in Seattle, the University of Sussex, and the Max Planck institute in Munich. Professor Tavassoli's early research focused on understanding the signaling and apoptosis pathways which are deregulated in cancer, before shifting towards the clinical application of her lab work. She currently leads a research team at KCL focused on developing genetic tests for the early detection and prediction of patient response to radiotherapy in head and neck cancer. They aim to develop more effective, less toxic cancer therapeutics. David J. Kerr is Professor of Cancer Medicine, at the University of Oxford, UK, and Adjunct Professor of Medicine at Weill Cornell College of Medicine in New York, USA. Professor Kerr has made a sustained and internationally recognised contribution to cancer care and research in the field of medical oncology over the past three decades. He has published over 400 papers in high profile journals, authored over twenty books, and has been awarded four prestigious, international research prizes, including the NHS's first Nye Bevan award for Innovation. His scientific standing has been recognised by election as Fellow of the Royal College of Physicians, Fellow of Academy of Medical Sciences, President of the European Society of Medical Oncology (2009-2011), and Founding Fellow of the European Academy of Cancer Sciences.